Metadon 60 MR

Metadon 60 MR contains Trimetazidine Hydrochloride (60 mg) in a modified-release formulation designed to enhance cardiac metabolism and improve energy production in heart cells. This medication is primarily used to manage stable angina pectoris by increasing exercise tolerance and reducing the frequency of angina attacks. The modified-release formulation allows for sustained therapeutic effects throughout the day making it a valuable option for patients seeking effective management of their cardiac condition.